Patient voice 'lost' in rush to specialised commissioning

Prostate cancer cells

A “ridiculously short” timeframe for consultation on plans for the future design of specialised services including rare cancers and neurosurgery has left insufficient time for meaningful patient engagement, patient groups have claimed.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here